These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 30847368)
1. rt-PA with remote ischemic postconditioning for acute ischemic stroke. Che R; Zhao W; Ma Q; Jiang F; Wu L; Yu Z; Zhang Q; Dong K; Song H; Huang X; Ji X Ann Clin Transl Neurol; 2019 Feb; 6(2):364-372. PubMed ID: 30847368 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of remote ischemic postconditioning after thrombolysis in patients with stroke. An JQ; Cheng YW; Guo YC; Wei M; Gong MJ; Tang YL; Yuan XY; Song WF; Mu CY; Zhang AF; Saguner AM; Li GL; Luo GG Neurology; 2020 Dec; 95(24):e3355-e3363. PubMed ID: 33028663 [TBL] [Abstract][Full Text] [Related]
3. Brain Protection Effects of Mild Hypothermia Combined with Distant Ischemic Postconditioning and Thrombolysis in Patients with Acute Ischemic Stroke. Jiao C; Liu C; Yang Z; Jin C; Chen X; Xue J; Zhang G; Pan C; Jia J; Hou X Ther Hypothermia Temp Manag; 2024 Sep; 14(3):172-178. PubMed ID: 37668993 [TBL] [Abstract][Full Text] [Related]
4. [Signifiance of brush sign on susceptibility-weighted imaging predicts hemorrhagic transformation after intravenous thrombolysis in patients with acute ischemic stroke]. Xu C; Chen ZC; Tang H; Xu MJ; Zhang S; Sun JZ; Lou M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 44(6):625-31. PubMed ID: 26822044 [TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients. Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1852-8. PubMed ID: 26044231 [TBL] [Abstract][Full Text] [Related]
6. Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke. He YD; Guo ZN; Qin C; Jin H; Zhang P; Abuduxukuer R; Yang Y Ann Clin Transl Neurol; 2020 Jun; 7(6):972-979. PubMed ID: 32472628 [TBL] [Abstract][Full Text] [Related]
7. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke. Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381 [TBL] [Abstract][Full Text] [Related]
8. An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke. Mandava P; Shah SD; Sarma AK; Kent TA Transl Stroke Res; 2015 Dec; 6(6):451-7. PubMed ID: 26385545 [TBL] [Abstract][Full Text] [Related]
9. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis. Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y; J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863 [TBL] [Abstract][Full Text] [Related]
11. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke. Liu J; Huang J; Xu H; Dai H Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497 [TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of serum MDA and 4-HNE levels on the occurrence of early neurological deterioration after intravenous thrombolysis with rt-PA IVT in patients with acute ischemic stroke. Zhang L; Li D; Zhang C; Zhang J; Xu J; Bai L; Xu J; Wang C J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107574. PubMed ID: 38214238 [TBL] [Abstract][Full Text] [Related]
14. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China. Yan X; Hu HT; Liu S; Sun YH; Gao X Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471 [TBL] [Abstract][Full Text] [Related]
15. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis? Pretnar Oblak J; Sabovic M; Frol S J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792 [TBL] [Abstract][Full Text] [Related]
16. Intravenous Recombinant Tissue-Type Plasminogen Activator: Influence on Outcome in Anterior Circulation Ischemic Stroke Treated by Mechanical Thrombectomy. Ferrigno M; Bricout N; Leys D; Estrade L; Cordonnier C; Personnic T; Kyheng M; Henon H Stroke; 2018 Jun; 49(6):1377-1385. PubMed ID: 29748424 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Prognosis in Ischemic Stroke Patients Treated with Intravenous Thrombolytic Therapy. Stefanovic Budimkic M; Pekmezovic T; Beslac-Bumbasirevic L; Ercegovac M; Berisavac I; Stanarcevic P; Padjen V; Jovanović DR J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):196-203. PubMed ID: 28341074 [TBL] [Abstract][Full Text] [Related]
18. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276 [TBL] [Abstract][Full Text] [Related]
19. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke. Medlin F; Amiguet M; Vanacker P; Michel P Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477 [TBL] [Abstract][Full Text] [Related]
20. Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion. Kahles T; Mono ML; Heldner MR; Baumgartner RW; Sarikaya H; Luft A; Bohlhalter S; Traenka C; Engelter ST; Kurka N; Köhrmann M; Curtze S; Michel P; Tatlisumak T; Nedeltchev K Stroke; 2016 Aug; 47(8):2133-5. PubMed ID: 27364530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]